Journal Mobile Options
Table of Contents
Vol. 84, No. 3, 2006
Issue release date: February 2007
Neuroendocrinology 2006;84:155–157

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: Why Such Guidelines and How We Went about It

Rindi G.a · de Herder W.W.b · O’Toole D.c · Wiedenmann B.d
aDepartment of Pathology and Laboratory Medicine, Università degli Studi, Parma, Italy; bDepartment of Endocrinology, Erasmus MC University, Rotterdam, The Netherlands; cDepartment of Gastroenterology, Beaujon Hospital, Clichy, France; dDepartment of Hepatology and Gastroenterology, Charité Universitätsmedizin, Berlin, Germany

First-Page Preview
Abstract of Introduction

 goto top of outline Author Contacts

Guido Rindi
Dipartimento di Patologia e Medicina di Laboratorio
Sezione di Anatomia Patologica, Università di Parma
Via Gramsci, 14, IT–43100 Parma (Italy)
Tel. +39 0521 702 636, Fax +39 0521 292 710, E-Mail

 goto top of outline Article Information

Published online: February 20, 2007
Number of Print Pages : 3

 goto top of outline Publication Details

Neuroendocrinology (International Journal for Basic and Clinical Studies on Neuroendocrine Relationships)

Vol. 84, No. 3, Year 2006 (Cover Date: February 2007)

Journal Editor: Millar, R. (Edinburgh)
ISSN: 0028–3835 (print), 1423–0194 (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.